Details for New Drug Application (NDA): 017672
✉ Email this page to a colleague
The generic ingredient in LITHONATE is lithium citrate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the lithium citrate profile page.
Summary for 017672
Tradename: | LITHONATE |
Applicant: | Solvay |
Ingredient: | lithium citrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | EQ 300MG CARBONATE/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription